Please provide your email address to receive an email when new articles are posted on . Cordis announced the FDA has approved its self-expanding vascular stent designed for transradial peripheral ...

ATLANTA--(BUSINESS WIRE)-- According to THE SAGE GROUP, almost 70% of the procedures performed to treat Peripheral Artery Disease (PAD) were endovascular (angioplasty, atherectomy and primary stenting ...

When the arteries that supply blood to the heart become narrowed or clogged, the condition is known as Coronary Artery Disease (CAD). It makes it difficult for the blood to flow to the heart muscle.

NATICK, Mass. and SAN FRANCISCO, Boston Scientific Corporation welcomed positive outcomes from the COBRA clinical trial, which evaluated post-dilation of nitinol stents using CryoPlasty® Therapy with ...

Chronic atherosclerotic peripheral arterial disease commonly causes narrowing or blockage of lower limb arteries. Symptoms include intermittent claudication, ischaemic rest pain, ulceration and ...

This section describes efficacy outcomes from the published literature that the Committee considered as part of the evidence about this procedure. For more detailed information on the evidence, see ...

The FiberNet Embolic Protection System is a temporary, intravascular, 0.014-inch wire-based filter system that is placed distal to a lesion to be treated by interventional procedures (Figures 1 & 2).

"Further analysis of these data will certainly help us understand the best therapeutic options for patients with symptomatic and asymptomatic carotid artery stenosis." The CAPTURE registry assessed ...

NATICK, Mass., Boston Scientific Corporation today announced that it has completed enrollment in the ORION clinical trial, which is designed to evaluate the Company's EPIC™ Self-Expanding Nitinol ...

Carotid stenting is a procedure in which a surgeon treats plaque from the carotid arteries and inserts a stent to hold them open. It is a minimally invasive treatment for carotid artery stenosis. The ...